Published in Subst Abuse Treat Prev Policy on February 09, 2016
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation (2001) 14.70
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
A global response to a global problem: the epidemic of overnutrition. Bull World Health Organ (2003) 2.42
Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord (2009) 1.63
Sex differences in obesity rates in poor countries: evidence from South Africa. Econ Hum Biol (2009) 1.56
In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens (2009) 1.52
Perceptions about body image and sizes among Black African girls living in Cape Town. Ethn Dis (2010) 1.35
Obesity and chronic kidney disease. Nefrologia (2011) 1.16
Perceptions of body image among Malaysian male and female adolescents. Singapore Med J (2009) 1.12
Prevalence of overweight and obesity and perception of healthy and desirable body size in urban, Ghanaian women. Ghana Med J (2012) 1.12
Body image of adolescents in a multi-ethnic Caribbean population. Eur J Clin Nutr (2003) 1.06
Interest in healthy living outweighs presumed cultural norms for obesity for Ghanaian women. Health Qual Life Outcomes (2006) 1.03
Anabolic steroid use: patterns of use and detection of doping. Sports Med (2008) 1.01
Adolescent body image and attitudes to anabolic steroid use. Am J Dis Child (1992) 0.95
The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. J Pediatr Hematol Oncol (2008) 0.94
Glucocorticoid therapy: minimizing side effects. J Pediatr (Rio J) (2007) 0.92
A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis. J Pediatr (Rio J) (2012) 0.92
Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents. Health Promot Int (2004) 0.91
Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo. Cardiovasc J Afr (2007) 0.90
Relationship of anthropometric indicators with blood pressure levels and the risk of hypertension in Nigerian adults. Int J Gen Med (2008) 0.90
Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed (2006) 0.88
Emerging modifiable risk factors for cardiovascular disease in women: obesity, physical activity, and sedentary behavior. Tex Heart Inst J (2013) 0.83
A fatality due to cyproheptadine and citalopram. J Anal Toxicol (2009) 0.80
A qualitative analysis of black and white British women's attitudes to weight and weight control. J Hum Nutr Diet (2011) 0.77